Results 111 to 120 of about 5,590,035 (204)

Immunogenicity of allogeneic mouse mesenchymal stem cells (MSC) [PDF]

, 2012
Adult mesenchymal stem cells (MSC) are multipotential cells which can differentiate into various cell types thus giving them utility in tissue engineering regenerative medicine and cell-based therapies.
Mukonoweshuro, Blessing
core   +1 more source

Allogeneic hematopoietic stem cell transplantation for elders with hematologic malignancies: haploidentical donor versus HLA-matched donor

Materials for manuscript "Allogeneic hematopoietic stem cell transplantation for elders with hematologic malignancies: haploidentical donor versus HLA-matched donor"
Xiang, Mengqi
core   +1 more source

Hematopoietic stem cell transplantation

Stem Cells and Cloning: Advances and Applications, 2010
Eleftheria Hatzimichael1, Mark Tuthill21Department of Haematology, Medical School of Ioannina, University of Ioannina, Ioannina, Greece; 2Department of Medical Oncology, Hammersmith Hospital, Imperial College National Health Service Trust, London ...
Eleftheria Hatzimichael, Mark Tuthill
doaj  

T-cell frequencies of CD8+ γδ and CD27+ γδ cells in the stem cell graft predict the outcome after allogeneic hematopoietic cell transplantation

, 2019
The impact of intra-graft T cells on the clinical outcome after allogeneic hematopoietic cell transplantation has been investigated. Most previous studies have focused on the role of alpha beta cells while gamma delta cells have received less attention ...
Önfelt, Björn,, Mattsson, Jonas,, Watz, Emma,, Michael Uhlin, Björn Önfelt, Stikvoort, Arwen,, Jonas Mattsson, Ahmed Gaballa, Gaballa, Ahmed,, Sundin, Mikael,, Mikael Sundin, Uhlin, Michael,, Arwen Stikvoort, Emma Watz, Sundin, M,, Mattsson, J,, Watz, E,, Stikvoort, A,, Uhlin, M,, Onfelt, B, Gaballa, A,   +20 more
core   +1 more source

Donor mesenchymal stem cells trigger chronic graft-versus-host disease following minor antigen-mismatched bone marrow transplantation [PDF]

, 2012
Chronic graft-versus-host disease (cGVHD) is a complication after minor antigen mismatched bone marrow transplantation (BMT) characterized by an autoimmune-type reaction in various organs.
Yumi Matsuzaki, Yoko Ogawa, Shigeto Shimmura, Yo Mabuchi, Sadafumi Suzuki, Yutaka Kawakami, Shinichiro Okamoto, Hideyuki Okano, Takaaki Inaba, Satoru Morikawa, Saori Yaguchi, Kazuo Tsubota, Tomonori Yaguchi   +12 more
core  

Comparative analysis of the value of allogeneic hematopoietic stem-cell transplantation in acute myeloid leukemia with monosomal karyotype versus other cytogenetic risk categories

, 2012
To determine to what extent allogeneic hematopoietic stem-cell transplantation (alloHSCT) quantitatively reduces relapse in acute myeloid leukemia with monosomal karyotype (MK-AML) compared with alternative postremission therapy and how it compares with ...
Kooy, Marinus van Marwijk, den Breems, D (Dimitri), Cornelissen, Jan J., van Marwijk Kooy, Marinus, Biemond, B.J. (Bart), Maertens, J. (Johan), Passweg, JR, Vellenga, E. (Edo), Biemond, Bart J, Gratwohl, A. (Alois), Breems, D.A. (Dimitri), van Putten, Wim L J, Maertens, Johan, Passweg, Jakob R, Gratwohl, AA, Ossenkoppele, G.J. (Gert), Putten, Wim, Pabst, Thomas, Passweg, J. (Jakob Robert), Wijermans, Pierre W, Verdonck, Leo F, Beverloo, Berna, Vellenga, E, Cornelissen, Jan J, Gratwohl, Alois A., Cornelissen, J.J. (Jan), Marwijk Kooy, M. (Marinus) van, Gratwohl, Alois A, Löwenberg, B. (Bob), van Putten, Wim L. J., Breems, Dimitri, Löwenberg, Bob; id_orcid, Maertens, J, Pabst, T, Verdonck, L.F. (Leo), Löwenberg, Bob, Ossenkoppele, GJ, Biemond, BJ, Wijermans, Pierre W., Putten, W.L.J. (Wim) van, Verdonck, Leo F., Beverloo, H.B. (Berna), Beverloo, H Berna, Ossenkoppele, Gert J., Kooy, MV, Wijermans, P.W. (Pierre), Verdonck, LF, Wijermans, PW, Vellenga, Edo, Pabst, T. (Thomas), Biemond, Bart J., Cornelissen, Jan, Ossenkoppele, Gert J, Passweg, Jakob R., Beverloo, H. Berna, Pabst, Thomas Niklaus   +55 more
core   +1 more source

High IL1R1 expression predicts poor survival and benefit from stem cell transplant in intermediate-risk acute myeloid leukemia from the Leucegene cohort

Biomarker Research
Background There is an unmet clinical need to identify patients with acute myeloid leukemia and intermediate-risk cytogenetics who benefit from allogeneic hematopoietic stem cell transplantation in first remission, especially among those without FLT3-ITD
Guillaume Richard-Carpentier, François Béliveau, Sandrine Lacoste, Banafsheh Khakipoor, Véronique Lisi, Michael Vladovsky, Miriam Marquis, Jean-François Spinella, Patrick Gendron, Sébastien Lemieux, Vincent-Philippe Lavallée, Guy Sauvageau, Josée Hébert   +12 more
doaj   +1 more source

Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome

, 2009
Allogeneic hematopoietic stem cell transplantation remains the only curative option for myelodysplastic syndrome, but patients with this disease are often older and frail, and treatment-related mortality and morbidity is a major obstacle to be overcome ...
Parmar, Simrit, Simrit Parmar, Marcos de Lima, de Lima, Marcos   +3 more
core   +1 more source

Getting fit for allogeneic hematopoietic cell transplantation [PDF]

Bone Marrow Transplantation, 2014
openaire   +2 more sources

Cardiovascular Events in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation

Allogeneic hematopoietic stem cell transplantation (HSCT) is a lifesaving treatment for certain blood cancers, but it may result in other complications.
Aghel, Nazanin
core   +2 more sources